Comorbidity in patients with cancer of the head and neck: Prevalence and impact on treatment and prognosis

Current Oncology Reports

Volumn 8, Issue 2, 2006, Pages 123-129

  Piccirillo, Jay F ^a   Vlahiotis, Anna ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ALCOHOL ABUSE; ANALYTIC METHOD; ANGINA PECTORIS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER THERAPY; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; FEMALE; GASTROINTESTINAL DISEASE; HEAD AND NECK CANCER; HEALTH CARE QUALITY; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY DISEASE; LEUKEMIA; LIVER DISEASE; LUNG DISEASE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MENTAL DISEASE; OBESITY; OBSERVATIONAL STUDY; OUTCOMES RESEARCH; PATIENT CARE; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PROGNOSIS; REVIEW; RHEUMATOLOGY; SQUAMOUS CELL CARCINOMA; STROKE; VALIDATION PROCESS; VEIN DISEASE;

COMORBIDITY; HEAD AND NECK NEOPLASMS; HEALTH STATUS INDICATORS; HUMANS; PREVALENCE; PROGNOSIS; QUALITY OF HEALTH CARE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33645545144     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-006-0047-z     Document Type: Review

References (21)

1. Piccirillo JF: Importance of comorbidity in head and neck cancer. Laryngoscope 2000, 110:593-602.
2. Kaplan MH, Feinstein AR: The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chron Dis 1974, 27:387-404.
3. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 1987, 40:373-383.
4. Piccirillo JF, Tierney RM, Costas I, et al.: Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004, 291:2441-2447.
5. Piccirillo JF, Lacy PD, Basu A, Spitznagel EL: Development of a new head and neck cancer-specific comorbidity index. Arch Otolaryngol Head Neck Surg 2002, 128:1172-1179.
6. Deleyiannis FWB, Thomas DB, Vaughan TL, Davis S: Alcoholism: Independent predictor of survival in patients with head and neck cancer. J Natl Cancer Inst 1996, 88:542-549.
7. Reid BC, Alberg AI, Klassen AC, et al.: Comorbidity and survival of elderly head and neck carcinoma patients. Cancer 2001, 92:2109-2116.
8. Warren JL, Klabunde CN, Schrag D, et al.: Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 2002, 40(Suppl):IV-3-18.
9. Reid BC, Alberg AJ, Klassen AC, et al.: A comparison of three comorbidity indexes in a head and neck cancer population. Oral Oncol 2002, 38:87-194.
10. Piccirillo JF, Creech CM, Zequeira R, et al.: Inclusion of comorbidity into oncology data registries. J Reg Manag 1999, 26:66-70.
11. Johnston AS, Piccirillo JF, Creech CM, et al.: Validation of a comorbidity education program. J Reg Manag 2001, 28:125-131.
12. Yancik R, Havlik RJ, Wesley MN, et al.: Cancer and comorbidity in older patients: A descriptive profile. Ann Epidemiol 1996, 6:399-412.
13. Derks W, de L, Hordijk GJ: Elderly patients with head and neck cancer: The influence of comorbidity on choice of therapy, complication rate, and survival. Curr Opin Otolaryngol Head Neck Surg 2005, 13:92-96.
14. Bernardi D, Barzan L, Franchin et al.: Treatment of head and neck cancer in elderly patients: State of the art and guidelines. Crit Rev Oncol Hematol 2005, 53:71-80.
15. Gourin CG, McAfee WJ, Neyman KM, et al.: Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck. Laryngoscope 2005, 115:1371-1375.
16. Ferrier MB, Spuesens EB, le Cessie S, Baatenburg de Jong RJ: Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg 2005, 131:27-32.
17. Hall SF, Groome PA, Rothwell D: The impact of comorbidity on the survival of patients with squamous cell carcinoma of the head and neck. Head Neck 2000, 22:317-322.
18. Hathaway B, Johnson JT, Piccirillo JF, et al.: Chemoradiation for metastatic SCCA: Role of comorbidity. Laryngoscope 2001, 111:1893-1895.
19. Medina JE: Clinical Practice Guidelines for the Diagnosis and Management of Cancer of the Head and Neck. Pittsburgh: American Society for Head and Neck Surgery; 1996.
20. Greenfield S, Aronow HU, Elashoff RM, Watanbe D: Flaws in mortality data. The hazards of ignoring comorbid disease. JAMA 1988, 260:2253-2255.
21. Hewitt M, Simone J, eds: Ensuring Quality Cancer Care. Washington DC: National Cancer Policy Board; 1999.